Stay updated on Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial

Sign up to get notified when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study of letetresgene autoleucel for advanced myxoid/round cell liposarcoma, with trial design, participant criteria, study locations, and measured outcomes. It also provides study documents and information about sharing participant-level data.
    Difference
    63%
    Check dated 2026-11-08T02:23:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:25:51.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T22:22:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:23:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:18:55.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record content and showing only a minimal header/footer.
    Difference
    20%
    Check dated 2026-09-19T20:33:02.000Z thumbnail image

Stay in the know with updates to Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.